Your browser doesn't support javascript.
New Mexico's COVID-19 Experience.
Jackson, Nicole R; Zeigler, Karen; Torrez, Mary; Makino, Yohsuke; Adolphi, Natalie L; Lathrop, Sarah; Decker, Lauren; Dvorscak, Lauren; Proe, Lori; Paul, Ian D; Zumwalt, Ross; Jarrell, Heather.
  • Jackson NR; From the Office of the Medical Investigator, University of New Mexico, Albuquerque, New Mexico.
  • Zeigler K; From the Office of the Medical Investigator, University of New Mexico, Albuquerque, New Mexico.
  • Torrez M; From the Office of the Medical Investigator, University of New Mexico, Albuquerque, New Mexico.
  • Adolphi NL; From the Office of the Medical Investigator, University of New Mexico, Albuquerque, New Mexico.
  • Lathrop S; From the Office of the Medical Investigator, University of New Mexico, Albuquerque, New Mexico.
  • Decker L; From the Office of the Medical Investigator, University of New Mexico, Albuquerque, New Mexico.
  • Dvorscak L; From the Office of the Medical Investigator, University of New Mexico, Albuquerque, New Mexico.
  • Proe L; From the Office of the Medical Investigator, University of New Mexico, Albuquerque, New Mexico.
  • Paul ID; From the Office of the Medical Investigator, University of New Mexico, Albuquerque, New Mexico.
  • Zumwalt R; From the Office of the Medical Investigator, University of New Mexico, Albuquerque, New Mexico.
  • Jarrell H; From the Office of the Medical Investigator, University of New Mexico, Albuquerque, New Mexico.
Am J Forensic Med Pathol ; 42(1): 1-8, 2021 Mar 01.
Artículo en Inglés | MEDLINE | ID: covidwho-1066484
ABSTRACT
ABSTRACT The 2019 novel coronavirus disease (COVID-19) has spread worldwide, infiltrating, infecting, and devastating communities in all locations of varying demographics. An overwhelming majority of published literature on the pathologic findings associated with COVID-19 is either from living clinical cohorts or from autopsy findings of those who died in a medical care setting, which can confound pure disease pathology. A relatively low initial infection rate paired with a high biosafety level enabled the New Mexico Office of the Medical Investigator to conduct full autopsy examinations on suspected COVID-19-related deaths. Full autopsy examination on the first 20 severe acute respiratory syndrome coronavirus 2-positive decedents revealed that some extent of diffuse alveolar damage in every death due to COVID-19 played some role. The average decedent was middle-aged, male, American Indian, and overweight with comorbidities that included diabetes, ethanolism, and atherosclerotic and/or hypertensive cardiovascular disease. Macroscopic thrombotic events were seen in 35% of cases consisting of pulmonary thromboemboli and coronary artery thrombi. In 2 cases, severe bacterial coinfections were seen in the lungs. Those determined to die with but not of severe acute respiratory syndrome coronavirus 2 infection had unremarkable lung findings.
Asunto(s)

Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Asunto principal: COVID-19 / Pulmón Tipo de estudio: Estudio de cohorte / Estudios diagnósticos / Estudio observacional / Estudio pronóstico País/Región como asunto: America del Norte / México Idioma: Inglés Revista: Am J Forensic Med Pathol Año: 2021 Tipo del documento: Artículo

Similares

MEDLINE

...
LILACS

LIS


Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Asunto principal: COVID-19 / Pulmón Tipo de estudio: Estudio de cohorte / Estudios diagnósticos / Estudio observacional / Estudio pronóstico País/Región como asunto: America del Norte / México Idioma: Inglés Revista: Am J Forensic Med Pathol Año: 2021 Tipo del documento: Artículo